Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08UGJ
|
|||
| Former ID |
DNAP001618
|
|||
| Drug Name |
Vincamine
|
|||
| Synonyms |
vincamine; 1617-90-9; Pervincamine; Devincan; Minorine; Vincamidol; Novicet; Monorin; Methyl vincaminate; Arteriovinca; Vincasaunier; Vinkametrin; Devinkan; Decincan; Vincapront; Vincafolina; Vincadar; Tripervan; Angiopac; Anasclerol; (+)-Vincamine; Equipur; Pervone; Oxygeron; Vincafor; Perval; Ocu-vinc; Vincamina [DCIT]; Vincimax; Vincamine base; Vincaminum [INN-Latin]; UNII-996XVD0JHT; Vincamine [INN:BAN:DCF]; Minorin; Vincachron; Vincapan; Vincamin; Vincagil; Vinca; Vinodrel retard; Vinca-Minor; Vinca-Ecobi; HSDB 7150; Anasclerol (base)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cerebrovascular disease [ICD-11: 8B2Z; ICD-10: I60-I69] | Approved | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H26N2O3
|
|||
| Canonical SMILES |
CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(C2)(C(=O)OC)O
|
|||
| InChI |
1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1
|
|||
| InChIKey |
RXPRRQLKFXBCSJ-GIVPXCGWSA-N
|
|||
| CAS Number |
CAS 1617-90-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
11442, 589983, 605104, 3137905, 8161547, 10321482, 11466299, 11467419, 11486097, 14901040, 15928943, 24712294, 24851332, 29204673, 29283340, 47573493, 47646670, 47795170, 48094657, 48243519, 48394062, 48424315, 49698413, 50063094, 50227572, 56463369, 57328977, 81092948, 85789347, 90455313, 92125108, 93619689, 96025360, 103763450, 103913976, 104336990, 121362779, 124812111, 124896567, 126623137, 126648205, 134224874, 134979517, 135652725, 136043617, 137006675, 143315335, 144204895, 144212285, 152035890
|
|||
| ChEBI ID |
CHEBI:9985
|
|||
| SuperDrug ATC ID |
C04AX07
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 349). | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.